1)Pellooski CE, Wilder RB, Ha CS et al:Clinical stage ⅠEA-ⅡEA orbital lymphomas:outcomes in the era of modern staging and treatment. Radiother Oncol 59:145-151, 2001
2)Hasegawa M, Kojima M, Shioya M et al:Treatment result of radiotheraphy for maligmant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57:172-176, 2003
3)Decaudin D, de Cremoux P, Incent-Salomon A et al:Ocular adnexal lymphoma a review of clinicopathologic features and treatment options. Blood 108:1451, 2006
4)Isaacson PG, Wright DH:Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2512-2524, 1984
5)Jaffe ES, Harris NL, Stein H et al(eds):WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001
6)Baldini L, Blini M, Guffanti A et al:Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol:779-781, 1998
7)Lee JL, Kim MK, Lee KH et al:Extranodal marginal zone B-cell lymhomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84:13-18, 2005
8)Coiffer B, Lepage E, Briere J et al:CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma. N Engl J Med 346:235, 2002